Pneumococal Community-Acquired Pneumonia in the Intensive Care Unit: Azithromycin Remains Protective Despite Macrolide Resistance

Streptococcus pneumoniae (SP) remains the leading pathogen in community-acquired pneumonia (CAP). Despite the increasing prevalence of macrolide resistance in SP, guidelines recommend the use of macrolides as part of a combination regiment for intensive care unit (ICU) patients with CAP. We sought to describe if macrolide resistance effects outcomes in SP CAP in the ICU and if macrolides remain associated with a mortality advantage in an era of greater resistance.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Tags: Original Research Source Type: research